Literature DB >> 29348183

Neurophysiological mechanisms of exertional dyspnoea in fibrotic interstitial lung disease.

Michele R Schaeffer1,2, Christopher J Ryerson1,3, Andrew H Ramsook1,2, Yannick Molgat-Seon1,4, Sabrina S Wilkie1, Satvir S Dhillon1, Reid A Mitchell1,2, A William Sheel4, Nasreen Khalil3, Pat G Camp1,2, Jordan A Guenette5,2,4.   

Abstract

Our understanding of the mechanisms of dyspnoea in fibrotic interstitial lung disease (ILD) is incomplete. The aims of this study were two-fold: 1) to determine whether dyspnoea intensity is better predicted by neural respiratory drive (NRD) or neuromechanical uncoupling (NMU) of the respiratory system in fibrotic ILD, and 2) to examine the effect of breathing 60% oxygen on NRD, NMU and dyspnoea ratings.Fourteen patients with fibrotic ILD were included. Visit 1 comprised a familiarisation incremental cycle exercise test, Visit 2 comprised a normoxic incremental cycling test to address Aim 1, and Visits 3 and 4 consisted of constant-load cycling while breathing room air or 60% oxygen to address Aim 2. Diaphragmatic electromyography (EMGdi) was used as a surrogate of NRD. NMU was calculated as the ratio between EMGdi (%max) and tidal volume (%vital capacity).On adjusted analysis, NMU and its constituents were all significantly associated with dyspnoea ratings during incremental cycling, with EMGdi having the strongest correlation. The between-treatment change in dyspnoea ratings during constant load cycling was only correlated with change in exercise endurance time and NMU.Dyspnoea more strongly reflected the level of EMGdi than NMU in fibrotic ILD. However, the improvement in dyspnoea with 60% oxygen was better predicted by improvements in NMU.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29348183     DOI: 10.1183/13993003.01726-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Effect of sequential high-flow nasal cannula oxygen therapy and non-invasive positive-pressure ventilation in patients with difficult weaning from mechanical ventilation after extubation on respiratory mechanics.

Authors:  Shi-Ya Wang; Han-Wen Liang; Guang-Sheng Lu; Zhen-Jie Jiang; Bao-Zhu Zhang; Qiu-Xue Deng; Qing-Wen Sun; Zhi-Min Lin; Qiang Chen; Chun Yang; Yuan-Da Xu; Ling Sang
Journal:  Ann Transl Med       Date:  2021-08

2.  Exercise Tolerance in Patients With Idiopathic Pulmonary Fibrosis, Effect of Supplemental Oxy-Gen.

Authors:  J Chlumský; L Stehlík; M Šterclová; J Smetanová; O Zindr
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

Review 3.  Measurement and Interpretation of Exercise Ventilatory Efficiency.

Authors:  Devin B Phillips; Sophie É Collins; Michael K Stickland
Journal:  Front Physiol       Date:  2020-06-25       Impact factor: 4.566

Review 4.  European Respiratory Society International Congress 2018: Allied Respiratory Professionals' report of highlighted sessions.

Authors:  Matthew Rutter; Carlos Augusto Camillo; Peter Coss; Andreja Sajnic; Aisling McGowan; Daniel Langer; Jana De Brandt; Christian Osadnik
Journal:  ERJ Open Res       Date:  2019-02-01

5.  Cardiorespiratory responses to muscle metaboreflex activation in fibrosing interstitial lung disease.

Authors:  Charlotte Chen; John Kolbe; Margaret L Wilsher; Sally De Boer; Julian F R Paton; James P Fisher
Journal:  Exp Physiol       Date:  2022-03-30       Impact factor: 2.858

Review 6.  IPF Respiratory Symptoms Management - Current Evidence.

Authors:  Piotr Janowiak; Amelia Szymanowska-Narloch; Alicja Siemińska
Journal:  Front Med (Lausanne)       Date:  2022-07-28

Review 7.  Functional Repercussions of Hypoxia-Inducible Factor-2α in Idiopathic Pulmonary Fibrosis.

Authors:  Ana Karen Torres-Soria; Yair Romero; Yalbi I Balderas-Martínez; Rafael Velázquez-Cruz; Luz Maria Torres-Espíndola; Angel Camarena; Edgar Flores-Soto; Héctor Solís-Chagoyán; Víctor Ruiz; Ángeles Carlos-Reyes; Citlaltepetl Salinas-Lara; Erika Rubí Luis-García; Jaime Chávez; Manuel Castillejos-López; Arnoldo Aquino-Gálvez
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.